0001493152-24-024120.txt : 20240617 0001493152-24-024120.hdr.sgml : 20240617 20240617162351 ACCESSION NUMBER: 0001493152-24-024120 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240613 FILED AS OF DATE: 20240617 DATE AS OF CHANGE: 20240617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kupchyk Areta CENTRAL INDEX KEY: 0001859718 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40388 FILM NUMBER: 241048599 MAIL ADDRESS: STREET 1: C/O ANEBULO PHARMACEUTICALS, INC. STREET 2: 1415 RANCH ROAD 620 SOUTH, SUITE 201 CITY: LAKEWAY STATE: TX ZIP: 78734 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Anebulo Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001815974 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 851170950 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: JFL CAPITAL MANAGEMENT STREET 2: 1017 RR 620 S, SUITE 107 CITY: LAKEWAY STATE: TX ZIP: 78734 BUSINESS PHONE: 737 203 5270 MAIL ADDRESS: STREET 1: JFL CAPITAL MANAGEMENT STREET 2: 1017 RR 620 S, SUITE 107 CITY: LAKEWAY STATE: TX ZIP: 78734 4 1 ownership.xml X0508 4 2024-06-13 0 0001815974 Anebulo Pharmaceuticals, Inc. ANEB 0001859718 Kupchyk Areta C/O ANEBULO PHARMACEUTICALS,INC., 1017 RANCH ROAD 620 SOUTH, STE. 107 LAKEWAY, TX 78734 1 0 0 0 0 Stock Option (right to buy) 2.10 2024-06-13 4 A 0 41667 0 A 2034-06-12 Common Stock 41667 41667 D Stock Option (right to buy) 2.10 2024-06-13 4 A 0 1324 0 A 2034-06-12 Common Stock 1324 1324 D These stock options vest 50% on the date of the 2024 annual meeting of shareholders and 50% on the one year anniversary of the date of grant These stock options vest on the earlier of November 30,2024 or the date of the 2024 annual meeting of shareholders Exhibit List: Exhibit 24.1 - Power of Attorney (Areta Kupchyk) /s/ Areta Kupchyk 2024-06-17 EX-24.1 2 ex24-1.htm

Exhibit 24.1

LIMITED POWER OF ATTORNEY FOR

SECTION 16 REPORTING OBLIGATIONS

Know all by these presents, that the undersigned hereby makes, constitutes and appoints each of Richard Cunningham or Daniel George of Anebulo Pharmaceuticals, Inc. (the “Company”), signing individually, the undersigned’s true and lawful attorney-in-fact and agent to:

	(1)	prepare, execute on behalf of the undersigned, and submit to the U.S. Securities and Exchange Commission (the “SEC”) any documents necessary or advisable to obtain EDGAR access codes or make any updates to the undersigned’s EDGAR access codes once obtained, enabling the undersigned to make electronic filings of reports with the SEC;

	(2)	execute for and on behalf of the undersigned, an officer, director or holder of 10% of more of a registered class of securities of the Company, Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and the rules thereunder;

	(3)	do and perform any and all acts for and on behalf of the undersigned that may be necessary or desirable to complete and execute such Form 3, 4 or 5, complete and execute any amendment or amendments thereto, and timely file such forms or amendments with the SEC and any stock exchange or similar authority; and

	(4)	take any other action of any nature whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.

The undersigned hereby grants to such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorney-in-fact, in serving in such capacity at the request of the undersigned, is not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Exchange Act.

This Power of Attorney shall remain in full force and effect until the earliest to occur of (a) the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, (b) revocation by the undersigned in a signed writing delivered to the foregoing attorney-in-fact or (c) until such attorney-in-fact shall no longer be employed by the Company, as applicable.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of June 14, 2024.

	/s/ Areta Kupchyk
	Areta Kupchyk